|
Basic Characteristics of Mutations
|
|
Mutation Site
|
V792I |
|
Mutation Site Sentence
|
We describe the first cases of an independently acquired V792I RNA-dependent RNA polymerase mutation developing in renal transplant recipients after remdesivir exposure. |
|
Mutation Level
|
Amino acid level |
|
Mutation Type
|
Nonsynonymous substitution |
|
Gene/Protein/Region
|
ORF1ab |
|
Standardized Encoding Gene
|
ORF1ab
|
|
Genotype/Subtype
|
- |
|
Viral Reference
|
-
|
|
Functional Impact and Mechanisms
|
|
Disease
|
COVID-19
|
|
Immune
|
- |
|
Target Gene
|
-
|
|
Clinical and Epidemiological Correlations
|
|
Clinical Information
|
Y |
|
Treatment
|
Remdesivir |
|
Location
|
USA |
|
Literature Information
|
|
PMID
|
36156117
|
|
Title
|
Remdesivir Resistance in Transplant Recipients With Persistent Coronavirus Disease 2019
|
|
Author
|
Hogan JI,Duerr R,Dimartino D,Marier C,Hochman SE,Mehta S,Wang G,Heguy A
|
|
Journal
|
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
|
|
Journal Info
|
2023 Jan 13;76(2):342-345
|
|
Abstract
|
New mutations conferring resistance to SARS-CoV-2 therapeutics have important clinical implications. We describe the first cases of an independently acquired V792I RNA-dependent RNA polymerase mutation developing in renal transplant recipients after remdesivir exposure. Our work underscores the need for augmented efforts to identify concerning mutations and address their clinical implications.
|
|
Sequence Data
|
-
|